相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of DNA fragmentation: the role of caspases and phosphorylation
Ikuko Kitazumi et al.
FEBS JOURNAL (2011)
Doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma
Lisa Hutchinson
Nature Reviews Clinical Oncology (2011)
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer
Kevin N. Dalby et al.
AUTOPHAGY (2010)
ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
Sebastien Cagnol et al.
FEBS JOURNAL (2010)
Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo
Gang Wei et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma A Randomized Trial
Ghassan K. Abou-Alfa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
Satoru Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Differences in Effects on Myocardium and Mitochondria by Angiogenic Inhibitors Suggest Separate Mechanisms of Cardiotoxicity
Kevin J. French et al.
TOXICOLOGIC PATHOLOGY (2010)
Targeting the RAF-MEK-ERK pathway in cancer therapy
Clara Montagut et al.
CANCER LETTERS (2009)
Tumour cell survival signalling by the ERK1/2 pathway
K. Balmanno et al.
CELL DEATH AND DIFFERENTIATION (2009)
Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial
H. Richly et al.
EUROPEAN JOURNAL OF CANCER (2009)
Apoptosis and autophagy: Targeting autophagy signalling in cancer cells -'trick or treats'?
Elisabeth A. Corcelle et al.
FEBS JOURNAL (2009)
Resistance to Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitors Correlates with Up-Regulation of the MEK/Extracellular Signal-Regulated Kinase Pathway in Hepatocellular Carcinoma Cells
Michele T. Yip-Schneider et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Multimodal approaches to the treatment of hepatocellular carcinoma
Giuseppe Cabibbo et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2009)
Dysregulation of apoptosis in hepatocellular carcinoma cells
Isabel Fabregat
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
Jiahao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
A dual role of p53 in the control of autophagy
Ezgi Tasdemir et al.
AUTOPHAGY (2008)
Inhibition of ERK attenuates autophagy and potentiates tumour necrosis factor-α-induced cell death in MCF-7 cells
U. Sivaprasad et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Novel advancements in the management of hepatocellular carcinoma in 2008
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Safety and anti-tumor activity of sorafenib (Nexavar((R))) in combination with other anti-cancer agents: a review of clinical trials
Chris H. Takimoto et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: Modulation by ERK, ROS, glutathione, and thioredoxin
Yongke Lu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
High-dose acetaminophen inhibits the lethal effect of doxorubicin in HepG2 cells: The role of P-glycoprotein and mitogen-activated protein kinase p44/42 pathway
Irena Manov et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P. Alao
MOLECULAR CANCER (2007)
Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death
Jian-hui Zhu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
From molecular biology to targeted therapies for hepatocellular carcinoma: The future is now
Roberta W. C. Pang et al.
ONCOLOGY (2007)
Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
Li Liu et al.
CANCER RESEARCH (2006)
A death-promoting role for extracellular signal-regulated kinase
Shougang Zhuang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Involvement of the multidrug resistance P-glycoprotein in acetaminophen-induced toxicity in hepatoma-derived HepG2 and Hep3B cells
Irena Manov et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
MEK/ERK signaling is a critical mediator for integrin-induced cell scattering in highly metastatic hepatocellular carcinoma cells
Nobuyuki Honma et al.
LABORATORY INVESTIGATION (2006)
Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity
Elisabeth Corcelle et al.
CANCER RESEARCH (2006)
Cyclin D1 degradation enhances endothelial cell survival upon oxidative stress
Pasquale Fasanaro et al.
FASEB JOURNAL (2006)
Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Eung-Ryoung Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006
CR Yu et al.
ONCOGENE (2005)
A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma
W Yeo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Autophagy in cell death: an innocent convict?
B Levine et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phosphorylation-dependent degradation of p300 by doxorubicin-activated p38 mitogen-activated protein kinase in cardiac cells
C Poizat et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Maturation of autophagic vacuoles in mammalian cells
Eeva-Liisa Eskelinen
AUTOPHAGY (2005)
Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors
D Strumberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Autophagy as a cell death and tumor suppressor mechanism
D Gozuacik et al.
ONCOGENE (2004)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma
CA Wiesenauer et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2004)
Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
S Schweyer et al.
BRITISH JOURNAL OF CANCER (2004)
Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes
S Shimizu et al.
NATURE CELL BIOLOGY (2004)
Sensory neurons with activated caspase-3 survive long-term experimental diabetes
C Cheng et al.
DIABETES (2003)
Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells
DW Stacey
CURRENT OPINION IN CELL BIOLOGY (2003)
Repression of mitogen-activated protein kinase (MAPK) phosphatase-1 by anthracyclines contributes to their antiapoptotic activation of p44/42-MAPK
GW Small et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Acetaminophen hepatotoxicity and mechanisms of its protection by N-acetylcysteine: a study of Hep3B cells
I Manov et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2002)
Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor of Cdc25 dual-specificity phosphatases
A Vogt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Detection of partially phosphorylated forms of ERK by monoclonal antibodies reveals spatial regulation of ERK activity by phosphatases
Z Yao et al.
FEBS LETTERS (2000)
分享论文
